Skip to main content

Table 4 Co-expression levels of PPAT and CAD with proteasome genes in 11 types of cancer

From: Systematic analyses of glutamine and glutamate metabolisms across different cancer types

Cancer

Gene

PPAT

CAD

PSMD1

PSMD11

PSMD14

PSME3

PSME4

PSMB5

PSMD1

PSMD2

PSME3

PSME4

BLCA

0.26

0.37

0.37

0.38

0.23

0.26

0.33

0.48

0.29

0.24

BRCA

0.36

0.42

0.32

0.37

0.29

  

0.33

 

0.35

COAD

 

0.27

0.38

0.33

    

0.29

0.36

HNSC

 

0.33

0.24

0.36

0.33

   

0.29

0.37

KICH

0.36

0.33

0.25

0.43

0.47

0.27

    

KIRC

0.26

0.38

  

0.29

  

0.22

 

0.37

KIRP

0.44

0.49

0.47

0.28

0.35

 

0.28

0.24

 

0.24

LIHC

0.24

0.27

0.25

0.45

    

0.43

 

LUAD

0.33

0.48

0.46

0.47

0.42

 

0.3

0.36

0.32

0.47

PRAD

 

0.35

 

0.43

0.36

  

0.29

0.34

0.26

THCA

 

0.48

 

0.42

0.25

  

0.4

  
  1. PPAT, phosphoribosyl pyrophosphate amidotransferase; CAD, carbamoyl-Phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase; PSMD1, proteasome 26S subunit, non-ATPase 1; PSMD11, proteasome 26S subunit, non-ATPase 11; PSMD14, proteasome 26S subunit, non-ATPase 14; PSME3, proteasome activator subunit 3; PSME4, proteasome activator subunit 4; PSMB5, proteasome subunit beta 5; PSMD2, proteasome 26S subunit, non-ATPase 2